HOTH
Hoth Therapeutics, Inc.NASDAQHealthcare$0.56+3.04%ClosedMarket Cap: $7.5M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.46
P/S
0.00
EV/EBITDA
-0.16
DCF Value
$0.40
FCF Yield
-127.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-139.8%
ROA
-164.0%
ROIC
-200.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-2.6M | $-2.7M | $-0.17 | — |
| FY 2025 | $0.00 | NaN% | $-11.1M | $-12.5M | $-0.90 | — |
| Q3 2025 | $0.00 | NaN% | $-4.1M | $-4.1M | $-0.30 | — |
| Q2 2025 | $0.00 | NaN% | $-2.2M | $-2.2M | $-0.17 | — |
| Q1 2025 | $0.00 | NaN% | $-3.5M | $-3.5M | $-0.36 | — |
| Q4 2024 | $0.00 | NaN% | $-2.4M | $-2.4M | $-0.33 | — |
| FY 2024 | $0.00 | NaN% | $-8.2M | $-8.2M | $-1.28 | — |
| Q3 2024 | $0.00 | NaN% | $-2.1M | $-2.1M | $-0.31 | — |
| Q2 2024 | $0.00 | NaN% | $-1.6M | $-1.6M | $-0.24 | — |
| Q1 2024 | $0.00 | NaN% | $-2.2M | $-2.1M | $-0.46 | — |
| Q4 2023 | $0.00 | NaN% | $-1.7M | $-1.7M | $-0.39 | — |
| FY 2023 | $0.00 | NaN% | $-7.7M | $-7.8M | $-2.30 | — |